KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cognex (CGNX) Cash & Equivalents: 2009-2025

Historic Cash & Equivalents for Cognex (CGNX) over the last 17 years, with Sep 2025 value amounting to $245.9 million.

  • Cognex's Cash & Equivalents rose 24.77% to $245.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $245.9 million, marking a year-over-year increase of 24.77%. This contributed to the annual value of $186.1 million for FY2024, which is 8.17% down from last year.
  • Latest data reveals that Cognex reported Cash & Equivalents of $245.9 million as of Q3 2025, which was up 37.13% from $179.3 million recorded in Q2 2025.
  • Over the past 5 years, Cognex's Cash & Equivalents peaked at $395.5 million during Q4 2023, and registered a low of $138.9 million during Q1 2024.
  • Over the past 3 years, Cognex's median Cash & Equivalents value was $179.3 million (recorded in 2025), while the average stood at $200.7 million.
  • Per our database at Business Quant, Cognex's Cash & Equivalents surged by 48.68% in 2023 and then plummeted by 50.17% in 2024.
  • Cognex's Cash & Equivalents (Quarterly) stood at $186.2 million in 2021, then dropped by 2.57% to $181.4 million in 2022, then climbed by 11.73% to $202.7 million in 2023, then dropped by 8.17% to $186.1 million in 2024, then grew by 24.77% to $245.9 million in 2025.
  • Its Cash & Equivalents was $245.9 million in Q3 2025, compared to $179.3 million in Q2 2025 and $143.7 million in Q1 2025.